Thyroid News

Patients with DICER1 syndrome face a 16-fold greater risk for thyroid cancer compared with people without the inherited genetic disorder, according to recent study findings.

Using genetically modified embryonic stem cells, researchers are exploring ways to more efficiently generate thyrocytes for use in studying thyroid disease, according to a press release from Boston University Medical Center.

A 73-year-old man had been diagnosed with colorectal cancer at an academic medical center. An F18-fluorodeoxyglucose PET-CT scan was performed for tumor staging, and a small hypermetabolic nodule was noted in the right thyroid lobe.

Worsening insulin resistance and higher cardiovascular disease risk were found in apparently healthy women with subclinical, hypothyroidism, study data show.

Among adults with Graves’ disease, radioactive iodine was more commonly used and yielded the best efficacy and safety profiles compared with antithyroid drugs and surgery, study data show.

As childhood cancer cure rates have substantially improved, the rate of late-onset endocrine complications among childhood cancer survivors has risen, with an estimated 50% of survivors experiencing complications ranging from thyroid dysfunction to obesity or type 2 diabetes during their lifetime, according to a recent analysis.

The risk for mortality was higher among adults undergoing hemodialysis who had high thyroid-stimulating hormone levels compared with those who had lower levels, study data show.

Hypothyroidism in babies influences insulin-secreting cells in and development of the pancrease, according to a press release from The Physiological Society.

Adults with follicular or medullary thyroid cancer have a higher risk for bone metastases or skeletal-related events compared with adults with papillary thyroid cancer, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

The risk for pregnancy loss may be decreased among women with subclinical hypothyroidism who are treated with thyroid hormone therapy, particularly when thyroid-stimulating hormone levels are between 4.1 mIU/L and 10 mIU/L, according to researchers.